AD Pharma Consult SRL
AD Pharma Consult reported total assets of 641,701 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
The score of AD Pharma Consult shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -54 % Total assets -46 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
AD Pharma Consult's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 426,824 € | ||||
| Equity | 428,324 € | ||||
| Cash | 175,280 € | ||||
| EBITDA | 564,955 € | ||||
| Total assets | 641,701 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 28 Jul 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 14 Jul 2023
- Year ended 31 Dec 2021filed on 08 Jun 2022
AD Pharma Consult's financial analysis
- Solvency66.7%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of AD Pharma Consult
AD Pharma Consult's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0737.800.410
- VAT number
- BE0737800410
- Peppol
- Registered · 0208:0737800410 · as of 11 Nov 2026
- Legal form
- SRL
- Incorporated
- 18 Nov 2019
- Registered office
- 1910 Kampenhout
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
AD Pharma Consult (SRL) has been based in Kampenhout since 2019, active in: business and other management consultancy activities. For 2025, it reports a net profit of 426,824 € and equity of 428,324 €; its revenue is not published. Its solvency stands at 66.7%, above the median of its sector (58.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to AD Pharma Consult
Companies in the same business, of comparable size and area, outside its group.
- Caspavel Malderen Business and other management consultancy activities Londerzeel · balance sheet 641,826 €
- Pianzo Business and other management consultancy activities Eupen · balance sheet 641,842 €
- Laxaz Business and other management consultancy activities Destelbergen · balance sheet 642,139 €
- Fineos Consulting Business and other management consultancy activities Charleroi · balance sheet 642,170 €
- Mont-Berg Conseil Business and other management consultancy activities Saint-Gilles · balance sheet 642,276 €
- Garage Beel Business and other management consultancy activities Tielt · balance sheet 641,004 €
- P.O. Management Business and other management consultancy activities Antwerp · balance sheet 640,542 €
- Nagasha Business and other management consultancy activities Lasne · balance sheet 643,038 €
Frequently asked questions about AD Pharma Consult
What is the revenue of AD Pharma Consult?
AD Pharma Consult files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of AD Pharma Consult?
In Belgium, the VAT number is the company number prefixed with BE: BE0737800410 for AD Pharma Consult, if the company is VAT-registered. Its company number (CBE) is 0737.800.410.
Where is the registered office of AD Pharma Consult?
According to the CBE register, the registered office of AD Pharma Consult is in 1910 Kampenhout.
What is the equity of AD Pharma Consult?
At the close of the 2025 financial year, the equity of AD Pharma Consult amounts to 428,324 €, a solvency of 66.7% of total assets.
Who manages AD Pharma Consult?
The register lists 2 active mandates at AD Pharma Consult. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of AD Pharma Consult
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →